Todos os estudos
RecrutamentoOBSERVACIONAL

Observatoire Des Patients Atteints de Laminopathies et Emerinopathies (Observatory for PAtients With Laminopathies and Emerinopathies)

The OPALE study is an observatory for people in France who have rare genetic conditions called laminopathies and emerinopathies. These conditions are caused by changes in specific genes (LMNA and EMD) and can affect muscles, especially the heart. Doctors want to gather detailed health information from people with these conditions, including their genetic test results and how their health changes over time. This will help them to understand the conditions better, find out how often different health problems occur, and identify factors that might predict the disease's course. There are currently no specific treatments to stop or slow down these diseases, so learning more about them is a crucial step towards developing new therapies in the future. Participation is based on having a confirmed genetic change and receiving regular follow-up care in France.

Em resumo

Status
Recrutamento
Patrocinador
Hospital Pitié-Salpêtrière
Meta de inscrição
800
Iniciar
11 Jul 2013
Conclusão estimada
11 Jul 2033

Sobre o que é este estudo?

Laminopathies and emerinopathies are a group of unusual conditions caused by tiny changes in our genes, specifically the LMNA and EMD genes. These changes can affect different parts of the body, but most commonly, they impact our muscles, including the heart. Heart problems can, unfortunately, be a serious concern for people with these conditions. Since the 1990s, medical understanding of these diseases has grown a lot, but there's still much to learn about exactly how these gene changes lead to the symptoms people experience.

At the moment, treatments mostly focus on managing symptoms, as there isn't a specific cure or a way to stop the conditions from progressing. That's why studies like OPALE are so important. The OPALE study, which stands for "Observatory for Patients With Laminopathies and Emerinopathies," is gathering detailed health information from people in France who have these conditions. It's like building a comprehensive health record for many patients all in one place, but with all personal details kept private.

The main goals of the OPALE study are to observe how these diseases naturally develop over time, understand how often different health issues (like heart problems or muscle weakness) occur, and identify any patterns or factors that might help predict how a person's condition will progress. By collecting this information carefully, researchers hope to gain a much clearer picture of laminopathies and emerinopathies, which is a vital step towards finding more effective treatments in the future.

Pontos principais

  • It's a study aiming to understand rare genetic muscle/heart conditions.
  • It collects anonymous patient information from existing medical records.
  • No new treatments or tests are involved, just observation.
  • It's for people in France with specific gene changes (LMNA or EMD).
  • Results could help develop better future treatments.
  • Participation is voluntary and confidential.

Quem pode ser elegível?

To be part of this study, you need to meet certain requirements. The most important is having a confirmed genetic change (mutation) in either the LMNA or EMD gene that doctors know causes laminopathy or emerinopathy. This genetic test result would have been provided by your doctor.

You also need to be receiving your regular medical care and check-ups in France. Finally, if you meet these criteria and agree to take part, you'll need to sign a consent form, which shows you understand the study and agree to participate willingly.

You would not be able to join the study if you do not wish to sign the consent form after understanding all the information provided.

Este estudo pode ser adequado para você?

Responda a estas perguntas rápidas para ver se você pode ser elegível. Este é apenas um guia — a decisão final é da equipe de pesquisa.

  1. I have been diagnosed with a laminopathy or emerinopathy.
  2. My diagnosis is confirmed by a genetic test showing a change in the LMNA or EMD gene.
  3. I receive my regular medical care for this condition in France.
  4. I am willing to sign a consent form to allow my information to be used anonymously.
Responda a todas as perguntas para ver o seu resultado.

O que envolve a participação?

This study is an "observatory," which means it primarily involves collecting information from your existing medical records and ongoing doctor visits. You won't be asked to take any new medications or undergo any extra tests specifically for the study. Instead, researchers will gather details from your regular check-ups, including genetic test results, information about your heart health, muscle strength, and any other relevant assessments. Your participation involves allowing your medical information (with your identity kept private) to be added to a secure database. There isn't a specific end date for your participation; instead, the registry will continue to collect information as long as you are receiving regular follow-up care and consent to be part of the study.

Riscos e benefícios potenciais

There are no direct medical benefits from taking part in this study, as it doesn't involve new treatments or medical interventions. However, the information gathered will be incredibly valuable to researchers, helping them to better understand laminopathies and emerinopathies. This understanding is a crucial step towards developing new and more effective treatments in the future, which could benefit others with these conditions. The main risk is a small chance that your information, although anonymised, could potentially be identified. However, strict measures are in place to protect your privacy and keep your data safe. You are free to withdraw from the study at any time without affecting your medical care.

Locations (28)

  • Centre de référence maladies neuromusculaires,CHU d'Angers
    Código postal verificado
    Angers, França· Recrutamento
  • CHU Strasbourg
    Código postal verificado
    Estrasburgo, França· Recrutamento
  • CHU Marseille
    Código postal verificado
    Marselha, França· Recrutamento
  • CHU Caen
    Código postal verificado
    Caen, França· Recrutamento
  • CHU Brest
    Código postal verificado
    Brest, France· Recrutamento
  • CHU Nimes
    Código postal verificado
    Nîmes, França· Recrutamento
  • CHU Bordeaux
    Código postal verificado
    Bordéus, França· Recrutamento
  • Centre de Référence de Pathologie NeuroMusculaire, CHU Toulouse
    Código postal verificado
    Toulouse, France· Recrutamento
  • CHU Montpelleir
    Código postal verificado
    Montpellier, France· Recrutamento
  • CHU Rennes
    Código postal verificado
    Rennes, França· Recrutamento
  • CHU Tours
    Código postal verificado
    Tours, France· Recrutamento
  • Centre de référence des maladies neuromusculaires, CHRU Lille
    Código postal verificado
    Lille, France· Recrutamento

Perguntas frequentes

What are laminopathies and emerinopathies?

They are rare genetic conditions caused by changes in specific genes (LMNA and EMD) that can affect muscles, especially the heart.

Is this a trial for a new medicine?

No, this is an 'observatory' study, meaning it collects existing health information from people to understand the conditions better, not to test new treatments.

Do I need to live in France to participate?

Yes, a key requirement is that you must be receiving your regular medical care and follow-ups in France.

Will my personal data be kept private?

Absolutely. All information collected will be kept confidential and your identity will be protected according to strict privacy rules.

What will happen with the information collected?

The information will help researchers understand how these conditions develop, how often problems occur, and what might predict their course, which could lead to better treatments in the future.

Como saber mais

Cathy Chikhaoui

Sempre consulte seu médico ou especialista antes de decidir participar de um estudo.

Interessado em participar?

Registre seu interesse

Compartilhe seus detalhes e a equipe de pesquisa para "Observatoire Des Patients Atteints de Laminopathies et Emeri…" entrará em contato com você se você for elegível. Sempre fale com seu médico antes de concordar em participar.

Discussão

Discussão da comunidade

Desenvolvido pelo nosso fórum em community.patient.info. Por favor, seja respeitoso — isto não é um conselho médico.